RecruitingNCT05371405

Machine Learning in Atrial Fibrillation


Sponsor

Stanford University

Enrollment

120 participants

Start Date

Feb 12, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

Atrial fibrillation is a serious public health issue that affects over 5 million Americans (Miyazaka, Circulation 2006) in whom it may cause skipped beats, dizziness, stroke and even death. Therapy for AF is currently suboptimal, in part because AF represents several disease states of which few have been delineated or used to successfully guide management. This study seeks to clarify this delineation of AF types using machine learning (ML).


Eligibility

Min Age: 22 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is using machine learning (AI-driven analysis) to study electrical patterns of atrial fibrillation (an irregular heart rhythm) during ablation procedures. Researchers are collecting electrical data from the heart to develop better AI models that can predict which ablation strategies will be most effective for individual patients. **You may be eligible if...** - You are undergoing ablation (a procedure to correct heart rhythm) at Stanford for paroxysmal atrial fibrillation (AF that stops on its own in under 7 days) or persistent AF (requires a procedure to stop it) - You have tried or cannot tolerate at least one anti-arrhythmic drug **You may NOT be eligible if...** - You have active coronary ischemia (blocked heart arteries causing symptoms) or severe heart failure - You have a blood clot in your heart - You are pregnant - You are unwilling or unable to give informed consent - You have rheumatic valve disease - You have blood clotting problems or vein filters Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Stanford University

Stanford, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05371405


Related Trials